Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
3,674
Views
35
CrossRef citations to date
0
Altmetric
Coronaviruses

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV

Ling Aoa Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Ting Lua Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Yu Caob The People’s Hospital of Tongliang District, Chongqing, People’s Republic of ChinaView further author information
,
Zhiwei Chena Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7951-3295View further author information
ORCID Icon,
Yuting Wanga Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Zisheng Lib The People’s Hospital of Tongliang District, Chongqing, People’s Republic of ChinaView further author information
,
Xingqian Renb The People’s Hospital of Tongliang District, Chongqing, People’s Republic of ChinaView further author information
,
Pan Xua Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Mingli Penga Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Min Chena Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Gaoli Zhanga Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Dejuan Xianga Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Dachuan Caia Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Peng Hua Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaView further author information
,
Xiaofeng Shia Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Dazhi Zhanga Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Hong Rena Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1126-1134 | Received 16 Dec 2021, Accepted 24 Mar 2022, Published online: 18 Apr 2022

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Guang Zeng, Jie Tang, Shuidong Feng, Liumei Xu, Xiaohui Wang & Zhengrong Yang. (2022) Failure to seroconvert after three doses of inactivated COVID-19 vaccines in a patient co-infected with HBV and HIV: A case report. Human Vaccines & Immunotherapeutics 18:6.
Read now

Articles from other publishers (34)

Thana Khawcharoenporn & Sirashat Hanvivattanakul. (2023) Safety profiles of homologous and heterologous regimens containing three major types of COVID-19 vaccine among people living with HIV. International Journal of STD & AIDS 35:4, pages 262-273.
Crossref
Mads Herluf Søndergaard, Jannifer Jasmin Thavarajah, Henry Churchill Henson & Christian Morberg Wejse. (2023) SARS‐CoV ‐2 vaccine immunogenicity for people living with HIV : A systematic review and meta‐analysis . HIV Medicine 25:1, pages 16-37.
Crossref
Yuxiao Wang, Xinquan Lan, Ying Qiao, Yuqi Huo, Li Wang, Shijie Liang, Maohe Yu, Moxin Song, Ying Yan, Bin Su & Junjie Xu. (2024) Safety and immunogenicity of homologous prime‐boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study. Journal of Medical Virology 96:1.
Crossref
Yasuhiro Umekage, Mayumi Hatayama, Akari Yagita, Kiichi Nitanai, Hiraku Yanada, Ryota Shigaki, Yoshinori Minami & Takaaki Sasaki. (2023) Monitoring SARS-CoV-2 Viral Load and CD4+ T-cell Count After ART in a Patient Diagnosed With AIDS Following SARS-CoV-2 Infection: A Case Report. Cureus.
Crossref
Xueying Fan, Yangguo Zhao, Fan Wu, Yue Yuan, Bing Lang, Di Yin, Zhongliang Xu, Shiqiang Jiang, Huachun Zou, Jianhui Yuan & Caijun Sun. (2023) Safety and Immunogenicity of SARS-CoV-2 Vaccines in People Living With HIV: A Systematic Review and Meta-analysis of Real-World Studies. Infectious Microbes and Diseases 5:4, pages 159-166.
Crossref
Nastiti Kaswandani, Bernie Endyarni Medise, Elcha Leonard, Hindra Irawan Satari, Julitasari Sundoro, Sri Rezeki Harun Hadinegoro, Ade Putra & Putra Fajar Angkasa. (2023) Safety profile of inactivated COVID-19 in healthy adults aged ≥ 18 years: A passive surveillance in Indonesia. PLOS ONE 18:10, pages e0286484.
Crossref
Maxine A. Höft, Wendy A. Burgers & Catherine Riou. (2023) The immune response to SARS-CoV-2 in people with HIV. Cellular & Molecular Immunology 21:2, pages 184-196.
Crossref
Lei Yang, YaMing Liu, Qiao Guo & DePeng Jiang. (2023) The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia. Open Medicine 18:1.
Crossref
Xinquan Lan, Bin Su, Shijie Liang, Maohe Yu, Ying Qiao, Li Wang, Moxin Song, Yuxiao Wang & Junjie Xu. (2023) Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China. Frontiers in Public Health 11.
Crossref
David W.J. GriffinRekha Pai MangaloreJennifer F. HoyJames H. McMahon. (2023) Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV. AIDS 37:9, pages 1345-1360.
Crossref
Yuting Tan, Shi Zou, Fangzhao Ming, Songjie Wu, Wei Guo, Mengmeng Wu, Weiming Tang & Ke Liang. (2023) A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines. Frontiers in Immunology 14.
Crossref
Qian Zhou, Furong Zeng, Yu Meng, Yihuang Liu, Hong Liu & Guangtong Deng. (2023) Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis. Scientific Reports 13:1.
Crossref
Lidan Hu, Jingmiao Sun, Yan Wang, Danny Tan, Zhongkai Cao, Langping Gao, Yuelin Guan, Xiuwei Jia & Jianhua Mao. (2023) A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations. Vaccines 11:6, pages 1045.
Crossref
Guang Zeng, Fei He, Xiaomin Zhang, Guilian Li, Xiaohui Wang, Yongxia Gan, Chenli Zheng, Jie Tang, Liumei Xu, Jin Zhao, Shuidong Feng & Zhengrong Yang. (2023) Antibody response to the third dose of inactivated COVID‐19 vaccine in people living with HIV (PLWH): A longitudinal cohort. Journal of Medical Virology 95:5.
Crossref
Monika Bociąga-Jasik, Martyna Lara, Aleksandra Raczyńska, Barbara Wizner, Stanisław Polański, Ewa Mlicka-Kowalczyk, Aleksander Garlicki & Marek Sanak. (2023) Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study. Vaccines 11:5, pages 893.
Crossref
Qian Zhou, Yihuang Liu, Furong Zeng, Yu Meng, Hong Liu & Guangtong Deng. (2023) Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis. Vaccines 11:4, pages 789.
Crossref
Jin-Wen Song, Lili ShenFu-Sheng Wang. (2023) Immunogenicity of COVID-19 Vaccination in People Living with HIV: Progress and Challenges. Infectious Diseases & Immunity 3:2, pages 90-96.
Crossref
Lei Yang, Feng Xiang, Dian Wang, Qiao Guo, Bing Deng, DePeng Jiang & Hong Ren. (2023) The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients. European Journal of Clinical Microbiology & Infectious Diseases 42:4, pages 503-512.
Crossref
Ting Lu, Zhiwei Chen, Yu Cao, Ling Ao, Zisheng Li, Xiaoyi Gu, Xingqian Ren, Yixuan Wang, Gaoli Zhang, Dejuan Xiang, Min Chen, Dachuan Cai, Peng Hu, Dazhi Zhang, Mingli Peng, Xiaofeng Shi & Hong Ren. (2023) Dynamic immunogenicity after primary and booster inactivated SARS‐CoV‐2 vaccination in people living with HIV: A longitudinal observational study. Journal of Medical Virology 95:4.
Crossref
Yuxiao Wang, Ying Qiao, Yuqi Huo, Li Wang, Shijie Liang, Maohe Yu, Xinquan Lan, Moxin Song, Xiangjun Zhang, Ying Yan & Junjie Xu. (2023) The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study. Frontiers in Immunology 14.
Crossref
Yi Wang, Jianhua Li, Wenhui Zhang, Shourong Liu, Liangbin Miao, Zhaoyi Li, Ai Fu, Jianfeng Bao, Lili Huang, Liping Zheng, Er Li, Yanjun Zhang & Jianhua Yu. (2023) Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV. Frontiers in Immunology 14.
Crossref
Vakada Lakshmi Mounika, V. Udaya Kumar, Sameer Dhingra, V. Ravichandiran, Krishna Pandey, Vipan Kumar Parihar & Krishna Murti. (2023) CD4 + Count: a Variable to Be Considered to Prioritize COVID-19 Vaccination in PLHIV. Current Pharmacology Reports 9:2, pages 90-97.
Crossref
Yulia Alexandrova, Alexis Yero, Ralph-Sydney Mboumba Bouassa, Eve Comeau, Suzanne Samarani, Zabrina L. Brumme, Mark Hull, Angela M. Crawley, Marc-André Langlois, Jonathan B. Angel, Curtis L. Cooper, Judy Needham, Terry Lee, Joel Singer, Aslam H. Anis, Cecilia T. Costiniuk & Mohammad-Ali Jenabian. (2023) SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study). Viruses 15:2, pages 575.
Crossref
Siliang Zhang, Jiaoxia He, Bin Tang, Qin Zhou, Yudong Hu, Yuan Yu, Jianwei Chen, Yi Liu, Chunmeng Li, Hong Ren & Xiaohui Liao. (2023) Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study. Journal of Clinical Medicine 12:3, pages 1225.
Crossref
Tianyu Zhao, Zongxing Yang, Yuxia Wu & Jin Yang. (2023) Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis. Epidemiology and Infection 151.
Crossref
Hu Li, Dachuan Cai, Depeng Jiang, Xingsheng Li, Xiaohui Liao, Dongfang Liu, Zuojin Liu, Peng Zhu, Guobing Yin, Jia Ming, Mingli Peng, Min Chen, Ning Ling, Yinghua Lan, Dazhi Zhang, Peng Hu & Hong Ren. (2023) Risk of waning humoral responses after inactivated or subunit recombinant SARS‐CoV‐2 vaccination in patients with chronic diseases: Findings from a prospective observational study in China. Journal of Medical Virology 95:1.
Crossref
Jin-Wen Song, Wei Hu, Lili ShenFu-Sheng Wang. (2022) Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients. Chinese Medical Journal 135:22, pages 2656-2666.
Crossref
Rui Song, Li Liu, Qingbo Pan, Jin Liu, Jiahe Tan, Juan Deng, Qin Deng, Zijin Lin, Min Chen, Mingli Peng, Hong Ren & Jia Ming. (2022) Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer. Frontiers in Immunology 13.
Crossref
Shi Zou, Wei Guo, Songjie Wu, Fangzhao Ming, Yuting Tan, Mengmeng Wu, Weiming Tang & Ke Liang. (2022) Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV. Frontiers in Immunology 13.
Crossref
Raynell Lang, Elizabeth Humes, Sally B. Coburn, Michael A. Horberg, Lily F. Fathi, Eric Watson, Celeena R. Jefferson, Lesley S. Park, Kirsha S. Gordon, Kathleen M. Akgün, Amy C. Justice, Sonia Napravnik, Jessie K. Edwards, Lindsay E. Browne, Deana M. Agil, Michael J. Silverberg, Jacek Skarbinski, Wendy A. Leyden, Cameron Stewart, Brenna C. Hogan, Kelly A. Gebo, Vincent C. Marconi, Carolyn F. Williams & Keri N. Althoff. (2022) Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US. JAMA Network Open 5:10, pages e2236397.
Crossref
Junyan Jin, Xiuwen Wang, Raphael Carapito, Christiane Moog & Bin Su. (2022) Advances in Research on COVID-19 Vaccination for People Living with HIV. Infectious Diseases & Immunity 2:4, pages 213-218.
Crossref
Liangyu Kang, Weijing Shang, Peng Gao, Yaping Wang, Jue Liu & Min Liu. (2022) Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis. Vaccines 10:9, pages 1569.
Crossref
Tong Li, Rui Song, Jingjie Wang, Jianbo Zhang, Hongxing Cai, Hongmei He, Wei Hu, Dajun Yu, Chuanhu Wang, Qingbo Pan, Mingli Peng, Hong Ren & Peng Zhu. (2022) Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer. International Journal of Infectious Diseases 122, pages 874-884.
Crossref
Guang Zeng, Liumei Xu, Shuidong Feng, Jie Tang, Xiaohui Wang, Guilian Li, Yongxia Gan, Chenli Zheng, Jin Zhao & Zhengrong Yang. (2022) IgG Antibody Responses and Immune Persistence of Two Doses of BBIBP-CorV Vaccine or CoronaVac Vaccine in People Living with HIV (PLWH) in Shenzhen, China. Vaccines 10:6, pages 880.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.